Poulton Jeffrey V. — Insider Trades & Holdings | InsiderBid

Poulton Jeffrey V.

Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗

Lifetime net: -$6M

Positions by company

Reported holding is the most recent post-transaction share count on a Table I row.

Every company this insider has reported trading in, with the value bought and sold at each and the date they last traded.
Ticker	Company	Bought	Sold	Net	Shares held	Last trade
CRVO	CervoMed Inc.	$0	$0	$0	—	Jun 8
ALNY	Alnylam Pharmaceuticals, INC.	$0	$6M	-$6M	61,805	Mar 4

CervoMed Inc.

$0

Bought

$0

Sold

$0

Held

—

Alnylam Pharmaceuticals, INC.

-$6M

Bought

$0

Sold

$6M

Held

61,805

Filing record

How quickly this filer reports. Section 16 allows two business days from the transaction.

All 9 filings we hold were filed within the two-business-day deadline.

Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings

Trade history

The 71 most recent Form 4 transactions.

Insider transactions, newest first: date, security, transaction type, size and a link to the filing each row came from.
Date	Ticker	Company	Type	Shares	Price	Value	Δ Own	Filing
Jun 8	CRVO	CervoMed Inc.	AGRANT◆	8,150	—	—	—	Open the original filing on SEC.gov
Mar 4	ALNY	Alnylam Pharmaceuticals,…	SSELL	223	$325.67	$72.6K	-0.4%

CRVOAGRANT◆—

CervoMed Inc.Jun 8

8,150 sh

ALNYSSELL$72.6K

Alnylam Pharmaceuticals,…Mar 4

223 sh @ $325.67 · -0.4% own

ALNYSSELL$94.5K

Alnylam Pharmaceuticals,…Mar 4

291 sh @ $324.88 · -0.5% own

ALNYSSELL$264.9K

Alnylam Pharmaceuticals,…Mar 4

818 sh @ $323.84 · -1.3% own

ALNYSSELL$120.8K

Alnylam Pharmaceuticals,…Mar 4

374 sh @ $323.01 · -0.6% own

ALNYSSELL$99.4K

Alnylam Pharmaceuticals,…Mar 4

309 sh @ $321.82 · -0.5% own

ALNYSSELL$73.8K

Alnylam Pharmaceuticals,…Mar 4

230 sh @ $320.81 · -0.4% own

ALNYSSELL$34.9K

Alnylam Pharmaceuticals,…Mar 4

109 sh @ $320.01 · -0.2% own

ALNYSSELL$36.4K

Alnylam Pharmaceuticals,…Mar 4

114 sh @ $319.03 · -0.2% own

ALNYAGRANT◆—

Alnylam Pharmaceuticals,…Mar 2

10,480 sh

ALNYSSELL$17.6K

Alnylam Pharmaceuticals,…Mar 2

53 sh @ $332.64 · <0.1% own

ALNYSSELL$42.8K

Alnylam Pharmaceuticals,…Mar 2

129 sh @ $331.93 · -0.2% own

ALNYSSELL$37.1K

Alnylam Pharmaceuticals,…Mar 2

112 sh @ $330.85 · -0.2% own

ALNYSSELL$77.2K

Alnylam Pharmaceuticals,…Mar 2

234 sh @ $329.71 · -0.4% own

ALNYSSELL$45.4K

Alnylam Pharmaceuticals,…Mar 2

138 sh @ $328.71 · -0.2% own

ALNYSSELL$148.8K

Alnylam Pharmaceuticals,…Mar 2

454 sh @ $327.67 · -0.7% own

ALNYSSELL$176.8K

Alnylam Pharmaceuticals,…Mar 2

541 sh @ $326.81 · -0.8% own

ALNYSSELL$115.9K

Alnylam Pharmaceuticals,…Mar 2

356 sh @ $325.63 · -0.5% own

ALNYSSELL$40.3K

Alnylam Pharmaceuticals,…Mar 2

124 sh @ $324.65 · -0.2% own

ALNYSSELL$21K

Alnylam Pharmaceuticals,…Mar 2

65 sh @ $323.62 · -0.1% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Mar 2

4,769 sh · +7.7% own

ALNYMEXER◆—

Alnylam Pharmaceuticals,…Feb 27

1,908 sh

ALNYMEXER—

Alnylam Pharmaceuticals,…Feb 27

1,908 sh · +3.2% own

ALNYSSELL$695.2K

Alnylam Pharmaceuticals,…Feb 13

2,242 sh @ $310.08 · -3.6% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Feb 12

4,579 sh · +8.0% own

ALNYSSELL$10.2K

Alnylam Pharmaceuticals,…Jan 12

27 sh @ $377.82 · <0.1% own

ALNYSSELL$12.8K

Alnylam Pharmaceuticals,…Jan 12

34 sh @ $375.65 · <0.1% own

ALNYSSELL$9.4K

Alnylam Pharmaceuticals,…Jan 12

25 sh @ $374.44 · <0.1% own

ALNYSSELL$2.2K

Alnylam Pharmaceuticals,…Jan 12

6 sh @ $372.46 · <0.1% own

ALNYSSELL$13.4K

Alnylam Pharmaceuticals,…Jan 12

36 sh @ $370.87 · <0.1% own

ALNYSSELL$27K

Alnylam Pharmaceuticals,…Jan 12

73 sh @ $369.48 · -0.1% own

ALNYSSELL$62.7K

Alnylam Pharmaceuticals,…Jan 12

170 sh @ $368.62 · -0.3% own

ALNYSSELL$27.9K

Alnylam Pharmaceuticals,…Jan 12

76 sh @ $367.40 · -0.1% own

ALNYSSELL$33.7K

Alnylam Pharmaceuticals,…Jan 12

92 sh @ $366.41 · -0.2% own

ALNYSSELL$148.1K

Alnylam Pharmaceuticals,…Jan 12

405 sh @ $365.56 · -0.7% own

ALNYSSELL$133.2K

Alnylam Pharmaceuticals,…Jan 12

365 sh @ $364.83 · -0.6% own

ALNYSSELL$31.6K

Alnylam Pharmaceuticals,…Jan 12

87 sh @ $363.55 · -0.1% own

ALNYSSELL$48.9K

Alnylam Pharmaceuticals,…Jan 12

135 sh @ $362.38 · -0.2% own

ALNYSSELL$65.4K

Alnylam Pharmaceuticals,…Jan 12

181 sh @ $361.45 · -0.3% own

ALNYSSELL$102.3K

Alnylam Pharmaceuticals,…Jan 12

284 sh @ $360.22 · -0.5% own

ALNYSSELL$56K

Alnylam Pharmaceuticals,…Jan 12

156 sh @ $359.14 · -0.3% own

ALNYSSELL$80.9K

Alnylam Pharmaceuticals,…Jan 12

226 sh @ $358.18 · -0.4% own

ALNYSSELL$62.9K

Alnylam Pharmaceuticals,…Jan 12

176 sh @ $357.17 · -0.3% own

ALNYSSELL$27.1K

Alnylam Pharmaceuticals,…Jan 12

76 sh @ $356.09 · -0.1% own

ALNYSSELL$27.7K

Alnylam Pharmaceuticals,…Jan 12

78 sh @ $355.16 · -0.1% own

ALNYSSELL$25.5K

Alnylam Pharmaceuticals,…Jan 12

72 sh @ $353.95 · -0.1% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Jan 11

6,193 sh · +11.5% own

ALNYSSELL$1.8K

Alnylam Pharmaceuticals,…Oct 2, 2025

4 sh @ $457.64 · <0.1% own

ALNYSSELL$87.4K

Alnylam Pharmaceuticals,…Oct 2, 2025

191 sh @ $457.43 · -0.4% own

ALNYSSELL$43.3K

Alnylam Pharmaceuticals,…Oct 2, 2025

95 sh @ $455.82 · -0.2% own

ALNYSSELL$144.2K

Alnylam Pharmaceuticals,…Oct 2, 2025

317 sh @ $454.84 · -0.6% own

ALNYSSELL$194.2K

Alnylam Pharmaceuticals,…Oct 2, 2025

428 sh @ $453.77 · -0.8% own

ALNYSSELL$393.4K

Alnylam Pharmaceuticals,…Oct 2, 2025

869 sh @ $452.69 · -1.6% own

ALNYSSELL$195.2K

Alnylam Pharmaceuticals,…Oct 2, 2025

432 sh @ $451.86 · -0.8% own

ALNYSSELL$317.4K

Alnylam Pharmaceuticals,…Oct 2, 2025

704 sh @ $450.81 · -1.2% own

ALNYSSELL$145.7K

Alnylam Pharmaceuticals,…Oct 2, 2025

324 sh @ $449.79 · -0.6% own

ALNYSSELL$105K

Alnylam Pharmaceuticals,…Oct 2, 2025

234 sh @ $448.77 · -0.4% own

ALNYSSELL$32.7K

Alnylam Pharmaceuticals,…Oct 2, 2025

73 sh @ $447.92 · -0.1% own

ALNYSSELL$67K

Alnylam Pharmaceuticals,…Oct 2, 2025

150 sh @ $446.53 · -0.3% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Oct 1, 2025

4,644 sh · +8.7% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Oct 1, 2025

3,108 sh · +6.2% own

ALNYSSELL$8.7K

Alnylam Pharmaceuticals,…Aug 18, 2025

19 sh @ $455.82 · <0.1% own

ALNYSSELL$178.3K

Alnylam Pharmaceuticals,…Aug 18, 2025

392 sh @ $454.84 · -0.8% own

ALNYSSELL$402.3K

Alnylam Pharmaceuticals,…Aug 18, 2025

886 sh @ $454.04 · -1.7% own

ALNYSSELL$242.8K

Alnylam Pharmaceuticals,…Aug 18, 2025

536 sh @ $452.96 · -1.0% own

ALNYSSELL$75.9K

Alnylam Pharmaceuticals,…Aug 18, 2025

168 sh @ $451.99 · -0.3% own

ALNYSSELL$28.4K

Alnylam Pharmaceuticals,…Aug 18, 2025

63 sh @ $450.92 · -0.1% own

ALNYSSELL$66.1K

Alnylam Pharmaceuticals,…Aug 18, 2025

147 sh @ $449.92 · -0.3% own

ALNYSSELL$28.2K

Alnylam Pharmaceuticals,…Aug 18, 2025

63 sh @ $447.98 · -0.1% own

ALNYAGRANT—

Alnylam Pharmaceuticals,…Aug 15, 2025

4,644 sh · +9.7% own

CRVOAGRANT◆—

CervoMed Inc.Jun 23, 2025

8,100 sh